<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04574778</url>
  </required_header>
  <id_info>
    <org_study_id>GSCHR19D.660</org_study_id>
    <nct_id>NCT04574778</nct_id>
  </id_info>
  <brief_title>Randomized Trial of Intraoperative IV Versus Preoperative Oral Acetaminophen During Ambulatory Lumbar Discectomy</brief_title>
  <official_title>Randomized Trial of IV Versus Oral Acetaminophen for Ambulatory Lumbar Discectomy or Single-level Decompression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effective non-opioid analgesics are of particular interest in ambulatory surgery, as&#xD;
      providers may be able to reduce pain while avoiding perioperative opioids that can delay same&#xD;
      day discharge. The value of maintaining an efficient flow of patients from the perioperative&#xD;
      area to discharge is an important metric for same day surgery centers, and an improvement in&#xD;
      efficiency with IV acetaminophen could potentially offset the increased cost of the&#xD;
      medication while providing a more pleasant surgical experience for patients. The goal of this&#xD;
      study is to compare the efficacy of intraoperative IV administration vs. preoperative oral&#xD;
      administration of acetaminophen on postoperative opioid utilization, patient-reported pain&#xD;
      scores, opioid-related adverse effects, and time to recovery and discharge from the&#xD;
      post-anesthesia care unit (PACU) after ambulatory lumbar discectomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 18, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Only those performing postoperative assessments and the study investigators will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative opioid usage</measure>
    <time_frame>1 day</time_frame>
    <description>Postoperative opioid usage over the first 24 hours will be reported in IV morphine equivalents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>1 day</time_frame>
    <description>assessed using the Quality of Recovery 15 scale, with a range of 0-150 (0 is the worst score and 150 is the best possible recovery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who report nausea or vomiting</measure>
    <time_frame>1 day</time_frame>
    <description>this will be a count of the number of patients who report nausea or vomiting in recovery room</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean pain score</measure>
    <time_frame>1 day</time_frame>
    <description>(0-10 numerical rating scale where 0=no pain and 10=worst pain imaginable) - this will be the mean pain rating upon entering pacu and at least 1 other time point in each study group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Spine Surgery</condition>
  <arm_group>
    <arm_group_label>Group 1: IV acetaminophen and oral placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 1 will receive 1000 mg of IV acetaminophen approximately 30 minutes prior to skin closure and will receive oral placebo in the holding area prior to surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: oral acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 2 will receive 1000 mg of PO acetaminophen in the holding area and will not receive an IV placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>1000 mg of oral acetaminophen preoperatively + IV placebo infusion intraoperatively 30 minutes prior to closure</description>
    <arm_group_label>Group 1: IV acetaminophen and oral placebo</arm_group_label>
    <arm_group_label>Group 2: oral acetaminophen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age greater than 18 years-old&#xD;
&#xD;
          -  Weight greater than 50 kg body weight&#xD;
&#xD;
          -  ASA physical status I-III&#xD;
&#xD;
          -  English-speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Weight less than 50 kg&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  Prior lumbar surgery&#xD;
&#xD;
          -  Contraindications to the administration of acetaminophen (e.g. allergy, liver failure,&#xD;
             etc)&#xD;
&#xD;
          -  Chronic pain conditions unrelated to back pain&#xD;
&#xD;
          -  Opioid tolerance ( defined as taking greater than oxycodone 20 mg daily for a week&#xD;
             during the past month).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Orthopaedic Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 29, 2020</study_first_submitted>
  <study_first_submitted_qc>September 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2020</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

